Search

Innovative Efforts to Distribute NX to Justice Involved Populations (Webinar)


The Bureau of Justice Assistance (BJA) leadership, in collaboration with the Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSAP) team and RTI International, invites you to this no-cost webinar on July 13, 2022, at 2:00 p.m., ET.

Please register to reserve your spot!

July 13, 2022 2:00 p.m. – 3:30 p.m., ET About the Webinar A recently emerging strategy for widespread distribution of naloxone to detainees released from jail facilities is through a vending machine. These machines can be customized to provide Naloxone and other supplies in a secure, organized, and stigma-free manner. We highlight three examples of states that have facilitated efforts to distribute Naloxone through county jail facilities.

We describe the process by which states can support Naloxone distribution, including the various funding streams used for this effort—BJA's COSSAP, the Centers for Disease Control and Prevention's Overdose Data to Action, and the Substance Abuse and Mental Health Services Administration's State Opioid Response—and then discuss the barriers and facilitators toward distributing Naloxone through vending machines in jail facilities. During this webinar, the presenters will:

  • Provide some understanding of why Naloxone distribution to returning citizens is important.

  • Describe the barriers and facilitators towards the distribution of naloxone through vending machines.

  • Give insight into multiple federal funding sources being used to purchase vending machines and the various types of products that communities are distributing.

Presenters

  • Brad Ray, Ph.D., RTI International

  • Derrick Jackson, Washtenaw County Sheriff's Office

  • Melissa Larson, M.A., North Carolina Harm Reduction Coalition

  • Justin Phillips, M.A., Overdose Lifeline, Inc.

Click Here to Register Today!

BJA’s COSSAP is a collaborative effort that includes the training and technical assistance teams from Advocates for Human Potential, Inc.; the Altarum Institute; the Center for Health and Justice at Treatment Alternatives for Safe Communities; the Institute for Intergovernmental Research; the National Criminal Justice Training Center of Fox Valley Technical College; the Prescription Drug Monitoring Program Training and Technical Assistance Center; and RTI International.


This project was supported by Grant No. 2017-AR-BX-K003 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Department of Justice's Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office for Victims of Crime, and the Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking (SMART). Points of view or opinions are those of the presenters and do not necessarily represent the official position or policies of the U.S. Department of Justice.